News
- Author:
- Nancy A. Melville
Publish date: December 30, 2022
“We feel these findings will help clinicians in discussions with patients and in clinical decision-making after adverse events develop,” one of the...
News
- Author:
- Nancy A. Melville
Publish date: December 23, 2022
Patients typically don’t fit into “convenient (DSM-5) buckets.” Consider likely comorbidities.
News
- Author:
- Nancy A. Melville
Publish date: December 9, 2022
The latest guideline from The Endocrine Society updates recommendations to reflect new treatment options for hypoglycemia prevention and treatment ...
News
- Author:
- Nancy A. Melville
Publish date: December 6, 2022
Patients with intermediate-risk papillary thyroid cancer who undergo lobectomy versus total thyroidectomy as the surgical approach show no signific...
News
- Author:
- Nancy A. Melville
Publish date: December 1, 2022
In many if not most cases, patients become addicted to fentanyl unknowingly, said Dr. Edwin Salsitz.
News
- Author:
- Nancy A. Melville
Publish date: November 11, 2022
“Telepsychiatry is here to stay because the patients and their families like it, and they will be the driving factors,” said Dr. Sanjay Gupta.
News
- Author:
- Nancy A. Melville
Publish date: November 8, 2022
The drug remains the only antipsychotic approved for treatment-resistant schizophrenia, yet with side effects and blood testing concerns, clozapine...
News
- Author:
- Nancy A. Melville
Publish date: November 3, 2022
Higher increases in radiofrequency energy strongly improve odds of achieving a greater than 50% reduction in nodule size.
News
- Author:
- Nancy A. Melville
Publish date: October 31, 2022
The implications of the atypical thyroiditis areas, which tend to be asymptomatic, are unclear.
News
- Author:
- Nancy A. Melville
Publish date: October 27, 2022
Raising the limits for tumor size and growth showed no increase in adverse outcomes or mortality.
News
- Author:
- Nancy A. Melville
Publish date: October 27, 2022
Withholding RAI therapy is clinically beneficial as it reduces exposure to radiation while having no negative effect on remission.
News
- Author:
- Nancy A. Melville
Publish date: October 25, 2022
Despite apparent lack of benefits, many still receive levothyroxine for subclinical hypothyroidism.
News
- Author:
- Nancy A. Melville
Publish date: October 24, 2022
A large study shows highest weight gain risk is with thyroidectomy, and radioiodine therapy is linked to better survival.
News
- Author:
- Nancy A. Melville
Publish date: October 10, 2022
“Weight lifting is independently associated with lower all-cause and CVD-specific mortality, regardless of aerobic activity.”
News
- Author:
- Nancy A. Melville
Publish date: October 3, 2022
Even prior to CAR T-cell therapy, patients developing related neurotoxic complications show elevated markers of neuronal injury.
